Medi Caps Share Price
Sector: Chemical Manufacturing
43.10 -1.05 (-2.38%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
43.07
Today’s High
44.95
52 Week Low
41.00
52 Week High
61.00
Key Metrics
- Market Cap (In Cr) 53.78
- Beta 1.05
- Div. Yield (%) 0
- P/B 0.46
- TTM P/E -
- Peg Ratio -
- Sector P/E 0
- Open Price 43.07
- Prev Close 44.15
Medi Caps Analysis
Price Analysis
-
1 Week0.8%
-
3 Months-13.55%
-
6 Month-18.44%
-
YTD-9.44%
-
1 Year-14.62%
Risk Meter
- 46% Low risk
- 46% Moderate risk
- 46% Balanced Risk
- 46% High risk
- 46% Extreme risk
Medi Caps News
How to turn your photos into Chibi figures: step-by-step guide to the trend
1 min read . 10:54 PM ISTConspiracy theories swirl about Blue Origin space mission after door gaffe
3 min read . 16 Apr 2025Medi Caps Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 27.35
- Selling/ General/ Admin Expenses Total
- 7.07
- Depreciation/ Amortization
- 1.69
- Other Operating Expenses Total
- 10.79
- Total Operating Expense
- 29.07
- Operating Income
- -1.72
- Net Income Before Taxes
- -1.25
- Net Income
- -2.24
- Diluted Normalized EPS
- -1.8
- Period
- 2024
- Total Assets
- 127.28
- Total Liabilities
- 6.3
- Total Equity
- 120.98
- Tangible Book Valueper Share Common Eq
- 74.45
- Period
- 2024
- Cashfrom Operating Activities
- 6.94
- Cashfrom Investing Activities
- -7.73
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -0.79
- Period
- 2023
- Total Revenue
- 49.37
- Selling/ General/ Admin Expenses Total
- 12.9
- Depreciation/ Amortization
- 1.74
- Other Operating Expenses Total
- 6.34
- Total Operating Expense
- 46.05
- Operating Income
- 3.32
- Net Income Before Taxes
- 4.92
- Net Income
- 1.76
- Diluted Normalized EPS
- 1.5
- Period
- 2023
- Total Assets
- 125.99
- Total Liabilities
- 7.42
- Total Equity
- 118.57
- Tangible Book Valueper Share Common Eq
- 72.52
- Period
- 2023
- Cashfrom Operating Activities
- -6.08
- Cashfrom Investing Activities
- -2.56
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -8.64
- Period
- 2022
- Total Revenue
- 69.87
- Selling/ General/ Admin Expenses Total
- 7.84
- Depreciation/ Amortization
- 1.81
- Other Operating Expenses Total
- 21.97
- Total Operating Expense
- 61.73
- Operating Income
- 8.14
- Net Income Before Taxes
- 10.06
- Net Income
- 10.08
- Diluted Normalized EPS
- 8.01
- Period
- 2022
- Total Assets
- 130.35
- Total Liabilities
- 14.09
- Total Equity
- 116.26
- Tangible Book Valueper Share Common Eq
- 70.66
- Period
- 2022
- Cashfrom Operating Activities
- 7.02
- Cashfrom Investing Activities
- -4.08
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- 2.95
- Period
- 2021
- Total Revenue
- 57.42
- Selling/ General/ Admin Expenses Total
- 6.71
- Depreciation/ Amortization
- 1.52
- Other Operating Expenses Total
- 10.47
- Total Operating Expense
- 48.06
- Operating Income
- 9.35
- Net Income Before Taxes
- 11.24
- Net Income
- 11.13
- Diluted Normalized EPS
- 11.14
- Period
- 2021
- Total Assets
- 114.82
- Total Liabilities
- 10.11
- Total Equity
- 104.71
- Tangible Book Valueper Share Common Eq
- 61.4
- Period
- 2021
- Cashfrom Operating Activities
- 15.32
- Cashfrom Investing Activities
- -9.7
- Cashfrom Financing Activities
- -0.06
- Net Changein Cash
- 5.56
- Period
- 2020
- Total Revenue
- 43.05
- Selling/ General/ Admin Expenses Total
- 11.04
- Depreciation/ Amortization
- 1.83
- Other Operating Expenses Total
- 12.05
- Total Operating Expense
- 51.74
- Operating Income
- -8.69
- Net Income Before Taxes
- -5.84
- Net Income
- -5.85
- Diluted Normalized EPS
- -4.69
- Period
- 2020
- Total Assets
- 95.21
- Total Liabilities
- 4.26
- Total Equity
- 90.95
- Tangible Book Valueper Share Common Eq
- 72.94
- Period
- 2020
- Cashfrom Operating Activities
- 4.63
- Cashfrom Investing Activities
- -5.8
- Cashfrom Financing Activities
- -0.06
- Net Changein Cash
- -1.23
- Period
- 2019
- Total Revenue
- 51.78
- Selling/ General/ Admin Expenses Total
- 9.56
- Depreciation/ Amortization
- 1.82
- Other Operating Expenses Total
- 11.27
- Total Operating Expense
- 48.99
- Operating Income
- 2.79
- Net Income Before Taxes
- 5.5
- Net Income
- 5.39
- Diluted Normalized EPS
- 4.32
- Period
- 2019
- Total Assets
- 106.61
- Total Liabilities
- 11.01
- Total Equity
- 95.6
- Tangible Book Valueper Share Common Eq
- 76.67
- Period
- 2019
- Cashfrom Operating Activities
- 5.96
- Cashfrom Investing Activities
- -5.75
- Cashfrom Financing Activities
- -0.05
- Net Changein Cash
- 0.16
- Period
- 2018
- Total Revenue
- 50.16
- Selling/ General/ Admin Expenses Total
- 8.76
- Depreciation/ Amortization
- 1.79
- Other Operating Expenses Total
- 11.83
- Total Operating Expense
- 49.87
- Operating Income
- 0.28
- Net Income Before Taxes
- 1.35
- Net Income
- 1.15
- Diluted Normalized EPS
- 0.92
- Period
- 2018
- Total Assets
- 100.91
- Total Liabilities
- 10.69
- Total Equity
- 90.22
- Tangible Book Valueper Share Common Eq
- 72.35
- Period
- 2018
- Cashfrom Operating Activities
- 4.2
- Cashfrom Investing Activities
- -4.09
- Cashfrom Financing Activities
- 0.08
- Net Changein Cash
- 0.2
- Period
- 2024-12-31
- Total Revenue
- 4.02
- Selling/ General/ Admin Expenses Total
- 1.95
- Depreciation/ Amortization
- 0.43
- Other Operating Expenses Total
- 1.66
- Total Operating Expense
- 6.23
- Operating Income
- -2.2
- Net Income Before Taxes
- -2.05
- Net Income
- -2.05
- Diluted Normalized EPS
- -1.64
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 8.3
- Selling/ General/ Admin Expenses Total
- 2.5
- Depreciation/ Amortization
- 0.43
- Other Operating Expenses Total
- 0.89
- Total Operating Expense
- 8.27
- Operating Income
- 0.03
- Net Income Before Taxes
- 0.31
- Net Income
- 0.31
- Diluted Normalized EPS
- 0.25
- Period
- 2024-09-30
- Total Assets
- 128.92
- Total Liabilities
- 5.19
- Total Equity
- 123.73
- Tangible Book Valueper Share Common Eq
- 76.65
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 5.52
- Cashfrom Investing Activities
- -4.87
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- 0.66
- Period
- 2024-06-30
- Total Revenue
- 6.19
- Selling/ General/ Admin Expenses Total
- 2.1
- Depreciation/ Amortization
- 0.43
- Other Operating Expenses Total
- 1.87
- Total Operating Expense
- 6.9
- Operating Income
- -0.7
- Net Income Before Taxes
- -0.56
- Net Income
- -0.56
- Diluted Normalized EPS
- -0.45
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 7.87
- Selling/ General/ Admin Expenses Total
- 2.66
- Depreciation/ Amortization
- 0.33
- Other Operating Expenses Total
- 2.61
- Total Operating Expense
- 8.7
- Operating Income
- -0.83
- Net Income Before Taxes
- -0.59
- Net Income
- -1.08
- Diluted Normalized EPS
- -0.87
- Period
- 2024-03-31
- Total Assets
- 127.28
- Total Liabilities
- 6.3
- Total Equity
- 120.98
- Tangible Book Valueper Share Common Eq
- 74.45
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 6.94
- Cashfrom Investing Activities
- -7.73
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -0.79
- Period
- 2023-12-31
- Total Revenue
- 7.07
- Selling/ General/ Admin Expenses Total
- 2.05
- Depreciation/ Amortization
- 0.45
- Other Operating Expenses Total
- 1.88
- Total Operating Expense
- 6.82
- Operating Income
- 0.25
- Net Income Before Taxes
- 0.34
- Net Income
- -0.16
- Diluted Normalized EPS
- -0.13
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 6.03
- Selling/ General/ Admin Expenses Total
- 1.96
- Depreciation/ Amortization
- 0.45
- Other Operating Expenses Total
- 1.43
- Total Operating Expense
- 5.99
- Operating Income
- 0.04
- Net Income Before Taxes
- 0.12
- Net Income
- 0.12
- Diluted Normalized EPS
- 0.09
- Period
- 2023-09-30
- Total Assets
- 125.67
- Total Liabilities
- 5.81
- Total Equity
- 119.86
- Tangible Book Valueper Share Common Eq
- 73.55
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 2.66
- Cashfrom Investing Activities
- -3.62
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -0.95
- Period
- 2023-06-30
- Total Revenue
- 6.38
- Selling/ General/ Admin Expenses Total
- 1.93
- Depreciation/ Amortization
- 0.45
- Other Operating Expenses Total
- 1.86
- Total Operating Expense
- 7.56
- Operating Income
- -1.18
- Net Income Before Taxes
- -1.11
- Net Income
- -1.11
- Diluted Normalized EPS
- -0.89
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 10.57
- Selling/ General/ Admin Expenses Total
- 3.48
- Depreciation/ Amortization
- 0.22
- Other Operating Expenses Total
- 1.96
- Total Operating Expense
- 10.01
- Operating Income
- 0.56
- Net Income Before Taxes
- 0.79
- Net Income
- 0.36
- Diluted Normalized EPS
- 0.3
- Period
- 2023-03-31
- Total Assets
- 125.99
- Total Liabilities
- 7.42
- Total Equity
- 118.57
- Tangible Book Valueper Share Common Eq
- 72.52
- Period
- 2023-03-31
- Cashfrom Operating Activities
- -6.08
- Cashfrom Investing Activities
- -2.56
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -8.64
- Period
- 2022-12-31
- Total Revenue
- 11.04
- Selling/ General/ Admin Expenses Total
- 2.58
- Depreciation/ Amortization
- 0.5
- Other Operating Expenses Total
- 1.07
- Total Operating Expense
- 9.87
- Operating Income
- 1.17
- Net Income Before Taxes
- 1.34
- Net Income
- -1.34
- Diluted Normalized EPS
- -1.01
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Medi Caps Technical
Moving Average
SMA
- 5 Day43.75
- 10 Day43.78
- 20 Day44.06
- 50 Day45.75
- 100 Day48.36
- 300 Day49.53
Medi Caps Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Aeonx Digital Technology
- 131.9
- 2.55
- 1.97
- 323.3
- 85
- 60.68
- The Phosphate Company
- 152
- 0
- 0
- 207.9
- 134.95
- 54.83
- Medi Caps
- 43.1
- -1.05
- -2.38
- 61
- 41
- 53.78
- Yash Chemex
- 52.13
- 0.34
- 0.66
- 63.4
- 39.2
- 53.4
- National Oxygen
- 107.5
- 2.95
- 2.82
- 184.9
- 99
- 54.21
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Aeonx Digital Technology
- 30.27
- 1.22
- 1.14
- 1.12
- The Phosphate Company
- 27.34
- 0.65
- 3.63
- 2.75
- Medi Caps
- -
- 0.45
- 2.8
- 6.1
- Yash Chemex
- -
- 1.51
- 7.49
- 3.15
- National Oxygen
- -
- -
- -
- 0.42
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 12-Feb-25
- Quarterly Results
- 12-Nov-24
- Quarterly Results
- 07-Aug-24
- Quarterly Results
- 23-May-24
- Quarterly Results
- 08-Feb-24
- Quarterly Results
- 08-Nov-23
- Quarterly Results
- 11-Aug-23
- Quarterly Results
- 23-May-23
- Quarterly Results
- 09-Feb-23
- Quarterly Results
- 10-Nov-22
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 26-Sept-24
- 07-Aug-24
- AGM
- 29-Sept-23
- 12-Sept-23
- AGM
- 28-Sept-21
- 12-Aug-21
- AGM



